AAAAAA

   
Results: 1-16 |
Results: 16

Authors: Berding, G Odin, P Brooks, DJ Nikkhah, G Matthies, C Peschel, T Shing, M Kolbe, H van den Hoff, J Fricke, H Dengler, R Samii, M Knapp, WH
Citation: G. Berding et al., Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [F-18]FDG-PET, MOVEMENT D, 16(6), 2001, pp. 1014-1022

Authors: Muller-Vahl, KR Koblenz, A Jobges, M Kolbe, H Emrich, HM Schneider, U
Citation: Kr. Muller-vahl et al., Influence of treatment of Tourette syndrome with Delta(9)-tetrahydrocannabinol (Delta(9)-THC) on neuropsychological performance, PHARMACOPS, 34(1), 2001, pp. 19-24

Authors: Muller-Vahl, KR Berding, G Brucke, T Kolbe, H Meyer, GJ Hundeshagen, H Dengler, R Knapp, WH Emrich, HM
Citation: Kr. Muller-vahl et al., Dopamine transporter binding in Gilles de la Tourette syndrome, J NEUROL, 247(7), 2000, pp. 514-520

Authors: Kolbe, H Dietzel, G
Citation: H. Kolbe et G. Dietzel, Technical validation of radioluminography systems, REGUL TOX P, 31(2), 2000, pp. S5-S14

Authors: Muller-Vahl, KR Kolbe, H Egensperger, R Dengler, R
Citation: Kr. Muller-vahl et al., Mitochondriopathy, blepharospasm, and treatment with botulinum toxin, MUSCLE NERV, 23(4), 2000, pp. 647-648

Authors: Sample, T Perujo, A Kolbe, H Mancinelli, B
Citation: T. Sample et al., The hydrogen permeation behaviour of aluminised coated martensitic steels under gaseous hydrogen, liquid Pb-17Li/hydrogen and cyclic tensile load, J NUCL MAT, 283, 2000, pp. 1272-1276

Authors: Sample, T Kolbe, H
Citation: T. Sample et H. Kolbe, Liquid metal embrittlement (LME) susceptibility of the 8-9% Cr martensiticsteels F82H-mod., OPTIFER IVb and their simulated welded structures in liquid Pb-17Li, J NUCL MAT, 283, 2000, pp. 1336-1340

Authors: Muller-Vahl, KR Berding, G Kolbe, H Meyer, GJ Hundeshagen, H Dengler, R Knapp, WH Emrich, HM
Citation: Kr. Muller-vahl et al., Dopamine D-2 receptor imaging in Gilles de la Tourette syndrome, ACT NEUR SC, 101(3), 2000, pp. 165-171

Authors: Muller-Vahl, KR Kolbe, H Schneider, U Emrich, HM
Citation: Kr. Muller-vahl et al., Cannabis in movement disorders, FORSCH KOMP, 6, 1999, pp. 23-27

Authors: Schnittger, C Kolbe, H Fedorowski, A Heidenreich, F
Citation: C. Schnittger et al., Neurocutaneous melanoblastosis associated with cerebral sinus venous thrombosis, J NEUROL, 246(3), 1999, pp. 218-220

Authors: Kolbe, H Lehmann, E Gunia, W Korner, S
Citation: H. Kolbe et al., Applications and characteristics of imaging plates as detector in neutron radiography at SINQ, NUCL INST A, 424(1), 1999, pp. 40-47

Authors: Muller-Vahl, KR Kolbe, H Dengler, R
Citation: Kr. Muller-vahl et al., Transient severe parkinsonism after acute organophosphate poisoning, J NE NE PSY, 66(2), 1999, pp. 253-254

Authors: Muller-Vahl, KR Schneider, U Kolbe, H Emrich, HM
Citation: Kr. Muller-vahl et al., Treatment of Tourette's syndrome with delta-9-tetrahydrocannabinol, AM J PSYCHI, 156(3), 1999, pp. 495-495

Authors: Weissenborn, K Kolbe, H
Citation: K. Weissenborn et H. Kolbe, The basal ganglia and portal-systemic encephalopathy, METAB BRAIN, 13(4), 1998, pp. 261-272

Authors: Perujo, A Kolbe, H
Citation: A. Perujo et H. Kolbe, The behaviour of the natural oxide of MANET as permeation barrier under cyclic loads: Self-healing, J NUCL MAT, 263, 1998, pp. 582-586

Authors: Muller-Vahl, KR Kolbe, H Schneider, U Emrich, HM
Citation: Kr. Muller-vahl et al., Cannabinoids: possible role in patho-physiology and therapy of Gilles de la Tourette syndrome, ACT PSYC SC, 98(6), 1998, pp. 502-506
Risultati: 1-16 |